Systemic Complications of the Bidirectional Intraoperative Chemotherapy With Intravenous Ifosfamide and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Using Cisplatin Plus Doxorubicin

Pleura and Peritoneum - Germany
doi 10.1515/pp-2019-0025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Systemic Inflammatory Response After Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The Perfusion Protocol Matters!

European Journal of Surgical Oncology
MedicineOncologySurgery
2019English

Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer

Journal of Peritoneum (and other serosal surfaces)
2017English

Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Gastroenterology Research and Practice
HepatologyGastroenterology
2012English

Technique of Post- Operative HIPEC (Hyperthermic Intraperitoneal Chemotherapy) Using Veress Needle and IVFluid Warmer in Patients With Epithelial Ovarian Cancer

Obstetrics & Gynecology International Journal
2017English

Bidirectional Treatment of Peritoneal Metastasis With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and Systemic Chemotherapy: A Systematic Review

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: Choosing the Right Candidates

Expert Review of Anticancer Therapy
OncologyPharmacology
2015English

A Comparison of Intravenous Plus Intraperitoneal Chemotherapy With Intravenous Chemotherapy Alone for the Treatment of Gastric Cancer: A Meta-Analysis

Scientific Reports
Multidisciplinary
2015English

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients With Peritoneal Metastases From Endometrial Cancer

Annals of Surgical Oncology
OncologySurgery
2017English

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Annals of Surgical Oncology
OncologySurgery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy